Technology of mammalian cell encapsulation.
暂无分享,去创建一个
P. Tresco | P. de Vos | H. Uludaǧ | P De Vos | P A Tresco | H Uludag | Hasan Uludağ | Paul de Vos
[1] G. Reach,et al. Complement activation by alginate-polylysine microcapsules used for islet transplantation. , 1994, Artificial organs.
[2] J. Vacanti,et al. Immunoisolation of xenogeneic islets using a living tissue engineered cartilage barrier. , 1997, Transplantation proceedings.
[3] W. Hymer,et al. Pituitary hollow fiber units in vivo and in vitro. , 1981, Neuroendocrinology.
[4] D. Ecker,et al. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. , 1995, Transplantation.
[5] P. Marchetti,et al. Preparation and characterization of permselective, biocompatible membranes for the macroencapsulation of pancreatic islets , 1994 .
[6] Shelley R. Winn,et al. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms , 1995, Experimental Neurology.
[7] K. Shakesheff,et al. Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules. , 1998, Journal of biomaterials science. Polymer edition.
[8] G. Parmiani,et al. In vitro "spontaneous" neoplastic transformation of mouse fibroblasts in diffusion chambers. , 1971, Journal of the National Cancer Institute.
[9] A. Anilkumar,et al. An encapsulation system for the immunoisolation of pancreatic islets , 1997, Nature Biotechnology.
[10] Mattheus F. A. Goosen,et al. Fundamentals of Animal Cell Encapsulation and Immobilization , 1992 .
[11] H. Sitter,et al. Amitogenic Alginates: Key to First Clinical Application of Microencapsulation Technology , 1998, World Journal of Surgery.
[12] K Burczak,et al. Long-term in vivo performance and biocompatibility of poly(vinyl alcohol) hydrogel macrocapsules for hybrid-type artificial pancreas. , 1996, Biomaterials.
[13] R. Bretzel,et al. PROTECTION OF ISLETS OF LANGERHANS FROM INTERLEUKIN‐1 TOXICITY BY ARTIFICIAL MEMBRANES , 1990, Transplantation.
[14] Myriam Schluep,et al. Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.
[15] T. Rytömaa,et al. REGULATION OF MATURATION RATE OF MOUSE GRANULOCYTES , 1977, Cell and tissue kinetics.
[16] P. Aebischer,et al. Treatment of amyotrophic lateral sclerosis using a gene therapy approach. , 1995, European neurology.
[17] P. Sanberg,et al. A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy , 1992, Neuroscience & Biobehavioral Reviews.
[18] M. Goosen,et al. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. , 1984, Biochimica et biophysica acta.
[19] R. L. Broughton,et al. Microencapsulation of mammalian cells in a water‐insoluble polyacrylate by coextrustion and interfacial precipitation , 1987, Biotechnology and bioengineering.
[20] M. Suthanthiran,et al. Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. , 1995, Transplantation.
[21] P. de Vos,et al. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. , 1996, Transplantation.
[22] P. de Vos,et al. Obstacles in the Application of Microencapsulation in Islet Transplantation , 1993, The International journal of artificial organs.
[23] R. Robitaille,et al. Alginate-poly-L-lysine microcapsule biocompatibility: a novel RT-PCR method for cytokine gene expression analysis in pericapsular infiltrates. , 1999, Journal of biomedical materials research.
[24] M. Pinget,et al. Influence of corona surface treatment on the properties of an artificial membrane used for Langerhans islets encapsulation: permeability and biocompatibility studies. , 1995, Biomaterials.
[25] W. J. Tze,et al. Implantable artificial endocrine pancreas unit used to restore normoglycaemia in the diabetic rat , 1976, Nature.
[26] C. Stiller,et al. HISTOLOGICAL AND IMMUNOPATHOLOGICAL ANALYSIS OF RECOVERED ENCAPSULATED ALLOGENEIC ISLETS FROM TRANSPLANTED DIABETIC BB/W RATS , 1992, Transplantation.
[27] H. Iwata,et al. Evaluation of Microencapsulated Islets in Agarose Gel as Bioartificial Pancreas by Studies of Hormone Secretion in Culture and by Xenotransplantation , 1989, Diabetes.
[28] R. L. Broughton,et al. Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. , 1990, Journal of biomedical materials research.
[29] W. Stevenson,et al. Microcapsules through polymer complexation. Part 3: Encapsulation and culture of human Burkitt lymphoma cells in vitro. , 1995, Biomaterials.
[30] T. Chang,et al. A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. , 1991, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.
[31] S. Bonner-Weir,et al. Dynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model , 1995, Diabetes.
[32] J. Kordower,et al. Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons , 1994, The Journal of comparative neurology.
[33] F. Stohlman,et al. Growth of Mouse Yolk Sac Cells Cultured in Vivo , 1976, British journal of haematology.
[34] Wolf Cf,et al. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. , 1975 .
[35] R. Lanza,et al. Transplantation of encapsulated cells and tissues. , 1997, Surgery.
[36] J. Remon,et al. The molecular weight cut‐off of microcapsules is determined by the reaction between alginate and polylysine , 1993, Biotechnology and bioengineering.
[37] Y. Ikada,et al. Permeability of filters used for immunoisolation. , 1996, Tissue engineering.
[38] Y Ikada,et al. Does immunoisolation need to prevent the passage of antibodies and complements? , 1995, Transplantation proceedings.
[39] Soon-Shiong. Treatment of type I diabetes using encapsulated islets. , 1999, Advanced drug delivery reviews.
[40] J. Hunt,et al. Techniques to investigate cellular and molecular interactions in the host response to implanted biomaterials. , 1997, Biomaterials.
[41] R. Lanza,et al. Encapsulated cell technology , 1996, Nature Biotechnology.
[42] S K Young,et al. Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. , 1996, Transplantation.
[43] Jeffrey A. Hubbell,et al. Biomaterials in Tissue Engineering , 1995, Bio/Technology.
[44] G. Wolters,et al. Effect of Alginate-Polylysine-Alginate Microencapsulation on In Vitro Insulin Release From Rat Pancreatic Islets , 1991, Diabetes.
[45] M. Sefton,et al. Tumor necrosis factor (TNFalpha) production by rat peritoneal macrophages is not polyacrylate surface-chemistry dependent. , 1999, Journal of biomedical materials research.
[46] M J Lysaght,et al. Recent progress in immunoisolated cell therapy , 1994, Journal of cellular biochemistry.
[47] M. Sefton,et al. Microencapsulation of mammalian cells in a hydroxyethyl methacrylate-methyl methacrylate copolymer: preliminary development. , 1988, Biomaterials, artificial cells, and artificial organs.
[48] Smadar Cohen,et al. Ionically crosslinkable polyphosphazene: a novel polymer for microencapsulation , 1990 .
[49] D. Hunkeler,et al. A SCREENING OF POLYMERS AS BIOMATERIALS FOR CELL ENCAPSULATION , 1997 .
[50] T A Dyakonov,et al. Synthetic Strategies for the Preparation of Precursor Polymers and of Microcapsules Suitable for Cellular Entrapment by Polyelectrolyte Complexation of Those Polymersa , 1997, Annals of the New York Academy of Sciences.
[51] D. Ducassou,et al. Microencapsulation of isolated pituitary cells by polyacrylamide microlatex coagulation on agarose beads. , 1991, Biomaterials.
[52] M. Aprahamian,et al. Diffusion properties of an artificial membrane used for Langerhans islets encapsulation: an in vitro test. , 1992, Biomaterials.
[53] P. Morris. Immunoprotection of therapeutic cell transplants by encapsulation. , 1996, Trends in biotechnology.
[54] P Aebischer,et al. TRANSPLANTATION IN HUMANS OF ENCAPSULATED XENOGENEIC CELLS WITHOUT IMMUNOSUPPRESSION: A PRELIMINARY REPORT , 1994, Transplantation.
[55] R. C. Johnson,et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. , 1995, Journal of biomedical materials research.
[56] Peter C. Johnson,et al. Meeting Report: Tissue Engineered Medical Products Standards: The Time Is Ripe , 1998 .
[57] P. Chang,et al. Permeability of alginate microcapsules to secretory recombinant gene products , 1996, Biotechnology and bioengineering.
[58] D. Cameron,et al. Sertoli Cell-Enriched Fractions in Successful Islet Cell Transplantation , 1993, Cell transplantation.
[59] P. Aebischer,et al. Mast cells and tissue reaction to intraperitoneally implanted polymer capsules. , 1991, Journal of biomedical materials research.
[60] Y. Ikada,et al. A newly developed three-layer agarose microcapsule for a promising biohybrid artificial pancreas: rat to mouse xenotransplantation. , 1996, Cell transplantation.
[61] H. Amemiya,et al. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. , 1994, Journal of biomedical materials research.
[62] F. F. Wang,et al. Surface modifications of alginate/poly(L-lysine) microcapsular membranes with poly(ethylene glycol) and poly(vinyl alcohol). , 1995, Biomaterials.
[63] P. Sanberg,et al. Polymer-Encapsulated PC12 Cells Promote Recovery of Motor Function in Aged Rats , 1993, Experimental Neurology.
[64] W. Stevenson,et al. Microcapsules through polymer complexation. II. By complex coacervation of polymers containing a low charge density. , 1991, Biomaterials.
[65] R. Gates,et al. REVERSAL OF STREPTOZOTOCIN-INDUCED DIABETES IN RATS BY INTRAPERITONEAL IMPLANTATION OF ENCAPSULATED NEONATAL RABBIT PANCREATIC TISSUE , 1977, The Lancet.
[66] P. Tresco,et al. An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats , 1989, Experimental Neurology.
[67] J. Fink,et al. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[68] R. Taub,et al. Amelioration of streptozotocin-induced diabetes in mice by the implantation of pancreatic islets in diffusion chambers. , 1976, The Mount Sinai journal of medicine, New York.
[69] M. Goosen,et al. Alginate‐Polylysine Microcapsules of Controlled Membrane Molecular Weight Cutoff for Mammalian Cell Culture Engineering , 1987 .
[70] G. Skjåk‐Braek,et al. SUCCESSFUL REVERSAL OF SPONTANEOUS DIABETES IN DOGS BY INTRAPERITONEAL MICROENCAPSULATED ISLETS , 1992, Transplantation.
[71] H. Amemiya,et al. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice. , 1992, Transplantation proceedings.
[72] S. Bystrický,et al. Interaction of alginates and pectins with cationic polypeptides , 1990 .
[73] R. Lanza,et al. Xenotransplantation of cells using biodegradable microcapsules. , 1999, Transplantation.
[74] C. Calleman,et al. The metabolism and pharmacokinetics of acrylamide: implications for mechanisms of toxicity and human risk estimation. , 1996, Drug metabolism reviews.
[75] P. Bruheim,et al. Alginate polycation microcapsules. I. Interaction between alginate and polycation. , 1996, Biomaterials.
[76] Y. Tsutsumi,et al. Evaluation of Angiogenic Inhibitors with an in vivo Quantitative Angiogenesis Method Using Agarose Microencapsulation and Mouse Hemoglobin Enzyme‐linked Immunosorbent Assay , 1996, Japanese journal of cancer research : Gann.
[77] P. Marchetti,et al. Polyurethane-polydimethylsiloxane (PU-PDMS) tubular membranes for pancreatic islet transplantation. Permselectivity and diffusion studies , 1992 .
[78] R. Padera,et al. Time course of membrane microarchitecture-driven neovascularization. , 1996, Biomaterials.
[79] L. Kurz. Propagation and hormone production by human normal and malignant trophoblast in rats. II. Choriocarcinoma in Millipore diffusion chambers in rats. , 1971, American journal of obstetrics and gynecology.
[80] F. Leblond,et al. Quantitative method for the evaluation of biomicrocapsule resistance to mechanical stress. , 1996, Biomaterials.
[81] J. A. Hubbell,et al. Modification of islet of langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. , 1994, Biotechnology and bioengineering.
[82] M. Sefton,et al. Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel. , 1992, Journal of biomedical materials research.
[83] I. Date,et al. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. , 1996, Journal of neurosurgery.
[84] C. Colton,et al. Bioengineering in development of the hybrid artificial pancreas. , 1991, Journal of biomechanical engineering.
[85] Ales Prokop,et al. Water Soluble Polymers for Immunoisolation II: Evaluation of Multicomponent Microencapsulation Systems , 1998 .
[86] A. Anilkumar,et al. New capsule with tailored properties for the encapsulation of living cells. , 1998, Journal of biomedical materials research.
[87] A. Fournier,et al. Studies of 300-microns microcapsules: I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability. , 1992, Transplantation proceedings.
[88] B. Říhová,et al. Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers , 1996 .
[89] G. Reach,et al. A Method for Obtaining Monodispersed Cells from Isolated Porcine Islets of Langerhans , 1995, The International journal of artificial organs.
[90] P. Morris. A critical review of immunosuppressive regimens. , 1996, Transplantation proceedings.
[91] D. Emerich,et al. Polymer-Encapsulated Genetically Modified Cells Continue to Secrete Human Nerve Growth Factor for over One Year in Rat Ventricles: Behavioral and Anatomical Consequences , 1996, Experimental Neurology.
[92] E. Klein,et al. Sensitization of rat T cells to syngeneic tumor cultures by cocultivation in diffusion chambers. , 1977, Zeitschrift fur Immunitatsforschung. Immunobiology.
[93] Anderson,et al. Host response to tissue engineered devices. , 1998, Advanced drug delivery reviews.
[94] G W Plant,et al. Neural tissue engineering: from polymer to biohybrid organs. , 1996, Biomaterials.
[95] W. Jochle. Forty years of control of the oestrous cycle in ruminants: progress made, unresolved problems and the potential impact of sperm encapsulation technology. , 1993 .
[96] P. Aebischer,et al. Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells , 1994, Experimental Neurology.
[97] H. Amemiya,et al. Microencapsulated islets in agarose gel as bioartificial pancreas for discordant xenotransplantation. , 1992, Transplantation proceedings.
[98] Ales Prokop,et al. Water Soluble Polymersfor Immunoisolation I: Complex Coacervation and Cytotoxicity , 1998 .
[99] Y. Ikada,et al. Entrapment of islets into reversible disulfide hydrogels. , 1998, Journal of biomedical materials research.
[100] J. Osebold,et al. Cellular Immunity of Mice Infected with Listeria monocytogenes in Diffusion Chambers , 1968, Journal of bacteriology.
[101] A. Anilkumar,et al. Control and measurement of permeability for design of microcapsule cell delivery system. , 1998, Journal of biomedical materials research.
[102] C. Sgro. Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review. , 1995, Toxicology.
[103] R. Gates,et al. Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans. , 1972, Lancet.
[104] P. de Vos,et al. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? , 1999, Diabetes.
[105] Ivar Storrø,et al. Alginate as immobilization material: III. Diffusional properties , 1992, Biotechnology and bioengineering.
[106] M. Sefton,et al. Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release. , 1993, Journal of biomedical materials research.
[107] Hydrogel Applications for Encapsulated Cellular Transplants , 1994 .
[108] P. Aebischer,et al. The Dawn of Biotechnology in Artificial Organs , 1995, ASAIO journal.
[109] M J Lysaght,et al. Artificial pancreas using living beta cells:. effects on glucose homeostasis in diabetic rats. , 1977, Science.
[110] A. Prokop,et al. Purification of Polymers Used for Fabrication of an Immunoisolation Barrier a , 1997, Annals of the New York Academy of Sciences.
[111] G. Korbutt,et al. Cotransplantation of Allogeneic Islets With Allogeneic Testicular Cell Aggregates Allows Long-Term Graft Survival Without Systemic Immunosuppression , 1997, Diabetes.
[112] M. Shoichet,et al. In vivo biostability of a polymeric hollow fibre membrane for cell encapsulation. , 1996, Biomaterials.
[113] Shelley R. Winn,et al. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line , 1991, Experimental Neurology.
[114] M. Pinget,et al. Pancreatic islet macroencapsulation: a new device for the evaluation of artificial membrane. , 1996, Artificial organs.
[115] P. Aebischer,et al. Review: Tissue engineering in the nervous system , 1994, Biotechnology and bioengineering.
[116] F T Gentile,et al. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. , 1991, Science.
[117] Y. Ikada,et al. Encapsulation of mammalian cells into synthetic polymer membranes using least toxic solvents. , 1997, Journal of biomaterials science. Polymer edition.
[118] B. Hering,et al. Large-scale production of Ba(2+)-alginate-coated islets of Langerhans for immunoisolation. , 2009, Experimental and clinical endocrinology.
[119] Li,et al. Materials for immunoisolated cell transplantation. , 1998, Advanced drug delivery reviews.
[120] B. Kulseng,et al. TNF Production from Peripheral Blood Mononuclear Cells in Diabetic Patients after Stimulation with Alginate and Lipopolysaccharide , 1996, Scandinavian journal of immunology.
[121] D K MacCallum,et al. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. , 1989, Connective tissue research.
[122] T. Chang,et al. Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.
[123] Sensenbrenner Ll,et al. Growth and differentiation of normal and leukemic human bone marrow cells cultured in diffusion chambers. , 1977 .
[124] L. G. Cima,et al. Engineering human tissue , 1993 .
[125] N. Déglon,et al. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. , 1997, Human gene therapy.
[126] P. De Vos,et al. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets , 1997, Diabetologia.
[127] G. Skjåk‐Braek,et al. An immunologic basis for the fibrotic reaction to implanted microcapsules. , 1991, Transplantation proceedings.
[128] F. Widmer,et al. A new multinozzle encapsulation/immobilisation system to produce uniform beads of alginate , 1998 .
[129] I. Chu,et al. Characterization of modified alginate-poly-L-lysine microcapsules. , 2008, Artificial organs.
[130] N. Forest,et al. Cartilage formation by fetal rat chondrocytes cultured in alginate beads: a proposed model for investigating tissue-biomaterial interactions. , 1998, Journal of biomedical materials research.
[131] C. Peterson,et al. Silica Sol-Gel Encapsulation of Pancreatic Islets , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[132] D. Ducassou,et al. Agarose encapsulation of islets of Langerhans: reduced toxicity in vitro. , 1987, Journal of microencapsulation.
[133] M. Sefton,et al. Metabolic Activity and Proliferation of Cho Cells in Hydroxyethyl Methacrylate-Methyl Methacrylate (Hema-Mma) Microcapsules , 1993, Cell transplantation.
[134] T. Loudovaris,et al. Destruction of xenografts but not allografts within cell impermeable membranes. , 1992, Transplantation proceedings.
[135] R. Palmiter,et al. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[136] P. Tresco. Encapsulated cells for sustained neurotransmitter delivery to the central nervous system , 1994 .
[137] P. Bruheim,et al. Alginate polycation microcapsules. II. Some functional properties. , 1996, Biomaterials.
[138] Clark K. Colton,et al. Engineering challenges in cellencapsulation technology , 1996 .
[139] C. Kiparissides,et al. Mathematical modelling of protein diffusion in microcapsules: A comparison with experimental results , 1991 .
[140] P. Vos,et al. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats , 1994 .
[141] F. Lim,et al. Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.
[142] Y. Tsutsumi,et al. A Quantitative in vivo Method of Analyzing Human Tumor‐induced Angiogenesis in Mice Using Agarose Microencapsulation and Hemoglobin Enzyme‐linked Immunosorbent Assay , 1995, Japanese journal of cancer research : Gann.
[143] W. D. Peterson,et al. Complex Coacervate Microcapsules for Mammalian Cell Culture and Artificial Organ Development , 1993, Biotechnology progress.
[144] T. Chang. Hybrid artificial cells: microencapsulation of living cells. , 1992, ASAIO journal.
[145] C. Baquey,et al. “Inverted Microcarriers” for Cell Cultures Made by Polymerization of Shells around Agarose Microspheres in a Non-Cytotoxic Procedure , 1991 .
[146] F T Gentile,et al. Poly(ethylene oxide)‐grafted thermoplastic membranes for use as cellular hybrid bio‐artificial organs in the central nervous system , 1994, Biotechnology and bioengineering.
[147] F. Leblond,et al. PROTECTION OF ISLETS OF LANGERHANS FROM ANTIBODIES BY MICROENCAPSULATION WITH ALGINATE‐POLY‐L‐LYSINE MEMBRANES1 , 1993, Transplantation.
[148] T. Harris,et al. Mathematical modelling of immobilized animal cell growth. , 1995, Artificial cells, blood substitutes, and immobilization biotechnology.
[149] P. Vos,et al. Upscaling the production of microencapsulated pancreatic islets , 1997 .
[150] Cole Lb,et al. An attack of tetanus. , 1968 .
[151] R. Langer,et al. A Novel Synthetic Method for Hybridoma Cell Encapsulation , 1991, Bio/Technology.
[152] H. Amemiya,et al. Agarose microcapsule applied in islet xenografts (hamster to mouse). , 1992, Transplantation proceedings.
[153] E. Doherty,et al. Transport characterization of membranes for immunoisolation. , 1996, Biomaterials.
[154] R. Simmons,et al. TNF and IL-1 generation by human monocytes in response to biomaterials. , 1992, Journal of biomedical materials research.
[155] A. Sun,et al. Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.
[156] J. Stillström. Induction of SV40-tumour immunity by SV40-transformed cells in diffusion chambers. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.
[157] D. Maysinger,et al. Drug delivery to the nervous system. , 1997, Trends in biotechnology.
[158] M. Pasch,et al. Complement as a promiscuous signal transduction device. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[159] D. Emerich,et al. Providing pharmacological access to the brain : alternate approaches , 1994 .
[160] M R Grever,et al. In vivo cultivation of tumor cells in hollow fibers. , 1995, Life sciences.
[161] S. Kubota,et al. In vitro studies on a new method for islet microencapsulation using a thermoreversible gelation polymer, N-isopropylacrylamide-based copolymer. , 2008, Artificial organs.
[162] A. Sun,et al. Encapsulation of viable cells within polyacrylate membranes , 1986, Biotechnology and bioengineering.
[163] A. Powers,et al. Evaluation of microcapsule permeability via inverse size exclusion chromatography. , 1996, Analytical biochemistry.
[164] O. Weislow,et al. Feasibility of cellular microencapsulation technology for evaluation of anti-human immunodeficiency virus drugs in vivo. , 1990, Journal of the National Cancer Institute.
[165] W. Stevenson,et al. Microcapsules through polymer complexation. I: Complex coacervation of polymers containing a high charge density. , 1991, Biomaterials.
[166] H. Ohtani,et al. Procollagen‐positive fibroblasts predominantly express fibrogenic growth factors and their receptors in human encapsulation process against foreign body , 1998, The Journal of pathology.
[167] A. Sun,et al. Encapsulation of Rat Islets of Langerhans Prolongs Xenograft Survival in Diabetic Mice , 1986, Diabetes.
[168] Y. Bae,et al. Insulin release from islets of Langerhans entrapped in a poly(N-isopropylacrylamide-co-acrylic acid) polymer gel. , 1999, Journal of biomaterials science. Polymer edition.
[169] M. Sefton,et al. Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400‐μm polyacrylate microcapsules by submerged nozzle–liquid jet extrusion , 1994, Biotechnology and bioengineering.
[170] H. Katinger,et al. Entrapment of animal cells for the production of biomolecules such as monoclonal antibodies. , 1983, Developments in biological standardization.
[171] Patrick A Tresco,et al. Polymer-Encapsulated PC12 Cells: Long-Term Survival and Associated Reduction in Lesion-Induced Rotational Behavior , 1992, Cell transplantation.
[172] A. Sun,et al. Porcine pancreatic islets: isolation, microencapsulation, and xenotransplantation. , 2008, Artificial organs.
[173] Patrick Aebischer,et al. Transplantation of a Polymer-Encapsulated Cell Line Genetically Engineered to Release NGF , 1993, Experimental Neurology.
[174] F. F. Wang,et al. Preparation and application of poly(vinylamine)/alginate microcapsules to culturing of a mouse erythroleukemia cell line. , 1992, Biotechnology and bioengineering.
[175] A. Cuschieri,et al. Microencapsulation of human cells: its effects on growth of normal and tumour cells in vitro. , 1991, British Journal of Cancer.
[176] D. Ducassou,et al. In situ polymerization of a microencapsulating medium round living cells. , 1988, Journal of biomedical materials research.
[177] K Hannig,et al. Production of mitogen‐contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis , 1992, Electrophoresis.
[178] R. Levin,et al. Purification and characteristics of an alginase from Alginovibrio aquatilis , 1977, Applied and environmental microbiology.
[179] G. Ackerman,et al. Bursa of Fabricius in Chickens: Possible Humoral Factor , 1965, Science.
[180] M. Sefton,et al. Microencapsulated human hepatoma (HepG2) cells: capsule-to-capsule variations in protein secretion and permeability , 1995 .
[181] R. C. Johnson,et al. Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy , 1997, Annals of the New York Academy of Sciences.
[182] P. Gullino,et al. Cell Culture on Artificial Capillaries: An Approach to Tissue Growth in vitro , 1972, Science.
[183] R. Nebel,et al. Microencapsulation of bovine spermatozoa for use in artificial insemination: a review. , 1993, Reproduction, fertility, and development.
[184] D. Osoba,et al. Evidence for a Humoral Thymus Factor Responsible for the Maturation of Immunological Faculty , 1963, Nature.
[185] G L Bartlett,et al. An improved design for general purpose diffusion chambers. , 1969, Transplantation.
[186] A. Rabinovitch. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. , 1998, Diabetes/metabolism reviews.
[187] T. Tsuji,et al. Encapsulated multicellular spheroids of rat hepatocytes produce albumin and urea in a spouted bed circulating culture system. , 1991, Artificial organs.
[188] T. Young,et al. Evaluation of asymmetric poly(vinyl alcohol) membranes for use in artificial islets. , 1996, Biomaterials.
[189] G. H. Algire,et al. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. , 1954, Journal of the National Cancer Institute.
[190] D. Despommier,et al. Diffusion chambers for inducing immunity to Trichinella spiralis in mice. , 1968, Experimental parasitology.
[191] P. Aebischer,et al. A bioartificial parathyroid. , 1986, ASAIO transactions.
[192] P. Chang,et al. Expression of human factor IX by microencapsulated recombinant fibroblasts. , 1993, Human gene therapy.
[193] M. Sefton,et al. Conformal Coating of Small Particles and Cell Aggregates at a Liquid‐Liquid Interface , 1999, Annals of the New York Academy of Sciences.
[194] F. Cerra,et al. Enhanced Morphology and Function in Hepatocyte Spheroids: A Model of Tissue Self-Assembly , 1998 .
[195] P. Chang,et al. Delivery of recombinant gene products with microencapsulated cells in vivo. , 1993, Human gene therapy.
[196] P. Chang,et al. Growth of recombinant fibroblasts in alginate microcapsules , 1994, Biotechnology and bioengineering.
[197] J. Vacanti,et al. A new method of xenotransplantation using autologous cartilage as an immunoisolation barrier for the transplantation of xenogeneic islets of Langerhans. , 1997, Transplantation proceedings.
[198] A. Sun,et al. The Use, in Diabetic Rats and Monkeys, of Artificial Capillary Units Containing Cultured Islets of Langerhans (Artificial Endocrine Pancreas) , 1977, Diabetes.
[199] P Aebischer,et al. Brain tissue reaction to permselective polymer capsules. , 1989, Journal of biomedical materials research.
[200] P. Gullino,et al. Hormone production by cells grown in vitro on artificial capillaries. , 1974, Experimental cell research.
[201] P. Aebischer,et al. Chitosan as a matrix for mammalian cell encapsulation. , 1994, Biomaterials.
[202] H Iwata,et al. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. , 1994, Journal of biomedical materials research.
[203] E. Shelton. Differentiation of mouse thymus cultured in diffusion chambers. , 1966, The American journal of anatomy.
[204] H. Ecke,et al. Formation of new bone in diffusion chambers. , 1970, Minnesota medicine.
[205] J. Hubbell,et al. Immunoisolation of Adult Porcine Islets for the Treatment of Diabetes Mellitus , 1997, Annals of the New York Academy of Sciences.
[206] P. Tresco,et al. Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. , 1991, Journal of biomechanical engineering.
[207] J. Lakey,et al. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. , 1996, The Journal of clinical endocrinology and metabolism.
[208] P. de Vos,et al. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. , 1996, Transplantation.
[209] N. Kedersha,et al. Clonogenic cytotoxicity testing by microdrop encapsulation , 1993, Nature.
[210] The rat epididymal fat pad as an implantation site for the study of microcapsule biocompatibility: validation of the method. , 1995, Journal of biomedical materials research.
[211] P. de Vos,et al. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. , 1997, Transplantation.
[212] S. Leskowitz,et al. Restoration of Antibody Producing Capacity in Bursectomized Chickens by Bursal Grafts in Millipore® Chambers.∗ , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[213] A. Sun,et al. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.
[214] M. Cooper,et al. Nonspecific stimulation of antibody production in surgically bursectomized chickens by bursa-containing diffusion chambers. , 1968, Journal of immunology.
[215] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[216] P Aebischer,et al. Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. , 1991, Biomaterials.
[217] Guohua Chen,et al. Temperature sensitivity of a hydrogel network containing different LCST oligomers grafted to the hydrogel backbone , 1998 .
[218] A. Sun,et al. Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. , 1992, Transplantation.
[219] Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. , 1996 .
[220] I. Chu,et al. Poly(ethylenimine)‐reinforced liquid‐core capsules for the cultivation of hybridoma cells , 1992, Biotechnology and bioengineering.
[221] M. Sefton,et al. Secretion of recombinant proteins from hydroxyethyl methacrylate‐methyl methacrylate capsules , 1996, Biotechnology and bioengineering.
[222] D. A. Cieslinski,et al. Tissue engineering of a bioartificial kidney , 1994, Biotechnology and bioengineering.
[223] P. Aebischer,et al. Encapsulated cells as therapy. , 1999, Scientific American.
[224] Takuyu Taki,et al. TRANSPLANTATION OF XENOGENEIC CELLS SECRETING β-ENDORPHIN FOR PAIN TREATMENT: ANALYSIS OF THE ABILITY OF COMPONENTS OF COMPLEMENT TO PENETRATE THROUGH POLYMER CAPSULES. , 1997, Cell transplantation.
[225] T. Chang,et al. Secretion of Erythropoietin from Microencapsulated Rat Kidney Cells: Preliminary Results , 1993, The International journal of artificial organs.
[226] B. Nordlinger,et al. Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes. , 1995, Biomaterials.
[227] M. Sefton,et al. Microencapsulation of live animal cells using polyacrylates , 1993 .
[228] L. Vanhaelst,et al. CORONARY-ARTERY DISEASE IN MYXŒDEMA , 1967 .
[229] D. Gray. Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. , 1997, British medical bulletin.
[230] P. Vos,et al. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules , 1997 .
[231] J. Nobrega,et al. HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis. , 1998, Biomaterials.
[232] P. Soon-Shiong,et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation , 1994, The Lancet.
[233] P. Aebischer,et al. Immunoisolated Xenogeneic Chromaffin Cell Therapy for Chronic Pain: Initial Clinical Experience , 1996 .
[234] J. Brash,et al. Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. , 1998, Journal of biomedical materials research.